Merck MRK announced that the FDA has approved its blockbuster PD-L1 inhibitor, Keytruda (pembrolizumab), and its subcutaneous ...

Perioperative Keytruda-Padcev for MIBC approved regardless of cisplatin eligibility ...

The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...

Rapid developments in muscle-invasive bladder cancer treatment are leading to new approaches to bladder preservation.

Discover how urine biopsy offers a less invasive and more accurate method for detecting bladder, kidney, and prostate cancers ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Ultrasound and artificial intelligence-guided algae microrobots delivered chemotherapy deep into tumors in mice, paving the ...

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

When bladder cancer metastasizes, it can cause pain in the areas it spreads to — mainly the lymph nodes, pelvis, lungs, liver, and bones. The severity of the pain can vary, too, depending on how ...

We’re going to beat it, ain’t we?” Deion Sanders asked one of his doctors, Dr. Janet Kukreja, during a press conference in ...